Specific References (5) | SL1851R has been referenced in 5 publications.
[IF=6.244] Meng-ke Fan. et al. Siglec-15 Promotes Tumor Progression in Osteosarcoma via DUSP1/MAPK Pathway. Front Oncol. 2021; 11: 710689 WB ; Human.
[IF=3.585] Sha J et al. Dexmedetomidine attenuates lipopolysaccharide-induced liver oxidative stress and cell apoptosis in rats by increasing GSK-3β/MKP-1/Nrf2 pathway activity via the α2 adrenergic receptor. Toxicol Appl Pharmacol. 2019 Feb 1;364:144-152. WB ; Rat.
[IF=4.522] Sha J et al. Dexmedetomidine improves acute stress‐induced liver injury in rats by regulating MKP‐1, inhibiting NF‐κB pathway and cell apoptosis. J Cell Physiol. 2019 Aug;234(8):14068-14078. IHF ; Rat.
[IF=3.83] Kouam et al. Induction of Mkp-1 and Nuclear Translocation of Nrf2 by Limonoids from Khaya grandifoliola C.DC Protect L-02 Hepatocytes against Acetaminophen-Induced Hepatotoxicity. (2017) Front.Pharmacol. 8:653 WB ; Human.
[IF=5.008] Kato, Hiroyuki, et al. "Connexin 32 dysfunction promotes ethanol-related hepatocarcinogenesis via activation of Dusp1-Erk axis." Oncotarget 7.2 (2016): 2009. IF(IHSLCF) ; Rat.